Economic Evaluation of Midazolam–Droperidol Combination, Versus Droperidol or Olanzapine for the Management of Acute Agitation in the Emergency Department: A Within-Trial Analysis

BACKGROUND: The combination of midazolam and droperidol has proven superior to droperidol or olanzapine monotherapy in the management of acute agitation in emergency departments (EDs). OBJECTIVE: This is the first economic analysis to evaluate the cost–benefit and cost effectiveness of the midazolam...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Celene Y. L., Hsueh, Ya-seng (Arthur), Knott, Jonathan C., Taylor, David McD, Chan, Esther W., Kong, David C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972118/
https://www.ncbi.nlm.nih.gov/pubmed/29623620
http://dx.doi.org/10.1007/s41669-017-0047-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972118/
https://www.ncbi.nlm.nih.gov/pubmed/29623620
http://dx.doi.org/10.1007/s41669-017-0047-y

Ejemplares similares